SITE009-0145

SITE009 (AUS) › SITE009-0145

SITE009-0145

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-02-10

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-20 (study day 147); relationship: NOT RELATED

mild assessed

Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-20 (study day 86); relationship: not assessed

mild assessed

Grade 1 Stomatitis — outcome: UNKNOWN; onset 2022-11-12 (study day 78); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.